Overview

Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution

Status:
NOT_YET_RECRUITING
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to explore pharmacodynamic effects and safety of IMP 08P2002F0 for dilation of the pupil, a solution combining two mydriatic agents tropicamide and phenylephrine hydrochloride at the concentrations of 0.34% and 2.5% respectively, versus Mydriasert
Phase:
PHASE1
Details
Lead Sponsor:
Unither Pharmaceuticals, France